Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren’s syndrome differ in molecular signatures and treatment perspectives

BACKGROUND: Previous studies and own clinical observations of patients with systemic lupus erythematosus (SLE) suggest that SLE harbors distinct immunophenotypes. This heterogeneity might result in differences in response to treatment in different subgroups and obstruct clinical trials. Our aim was...

詳細記述

保存先:
書誌詳細
出版年:Arthritis Res Ther
主要な著者: Idborg, Helena, Zandian, Arash, Sandberg, Ann-Sofi, Nilsson, Bo, Elvin, Kerstin, Truedsson, Lennart, Sohrabian, Azita, Rönnelid, Johan, Mo, John, Grosso, Giorgia, Kvarnström, Marika, Gunnarsson, Iva, Lehtiö, Janne, Nilsson, Peter, Svenungsson, Elisabet, Jakobsson, Per-Johan
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378708/
https://ncbi.nlm.nih.gov/pubmed/30777133
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1836-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料